Skip to main content

Month: May 2021

LexaGene Expands its Sales Team

BEVERLY, Mass., May 11, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce the hiring of four additional sales representatives, including three for the veterinary market and one for the contract drug manufacturing market. Dr. Jack Regan, LexaGene’s CEO and Founder states, “We are excited to have recruited very talented and experienced sales representatives from some of the biggest names in veterinary healthcare. Our new sales representatives have universally expressed optimism about selling LexaGene’s technology into veterinary hospitals, and the same is true for our sales representative targeting contract drug manufacturing organizations. Our rapidly growing sales team...

Continue reading

Verano Upsizes Existing Credit Agreement by US$100 Million with a 9.75% Annual Interest Rate on a Non-Dilutive Basis

Reduces borrowing costs with one of the industry’s leading annual interest rates of 9.75% Credit agreement is non-dilutive Improves liquidity and operational flexibility Supports the Company’s continued strategic growth plansCHICAGO, May 11, 2021 (GLOBE NEWSWIRE) — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced it has entered into an Amended and Restated Credit Agreement (the “Restated Credit Agreement”) for a senior secured term loan of US$130 million. The Restated Credit Agreement has a maturity date of May 30, 2023, and provides for additional, non-dilutive funding of US$100 million, with an annual interest rate of 9.75% for the incremental amount. Chicago Atlantic Advisers, LLC (“Chicago Atlantic”) will act as the administrative agent...

Continue reading

MediPharm Labs Sets Date to Report First Quarter 2021 Financial Results

TORONTO, May 11, 2021 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce it will release first quarter financial results for the three month period ended March 31, 2021 before markets open on Monday, May 17, 2021. MediPharm Labs executive management team will also host a conference call and audio webcast on Monday, May 17, 2021, at 8:30 a.m. eastern time to discuss the Company’s financial results and outlook. Audio Conference Call Dial In Details: Toll-free number: +1-833-502-0471 / International number: +1-236-714-2179 / Conference ID: 5847315 Participants are asked to dial in approximately 15 minutes before the start...

Continue reading

Progenity Receives Funding from Crohn’s & Colitis Foundation IBD Ventures Fund to Develop Drug Delivery System for IBD

SAN DIEGO, May 11, 2021 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success developing and commercializing molecular testing products, announced today that it has received funding from the Crohn’s & Colitis Foundation’s IBD Ventures program to further develop Progenity’s first-in-class oral Drug Delivery System (DDS) for delivery of targeted therapeutics for inflammatory bowel disease (IBD). The DDS capsule is an orally ingestible and self-guided drug delivery device under development, which is designed to deliver doses of therapeutic compounds formulated in proprietary solutions to a defined location within the gastrointestinal (GI) tract. Current drug treatments for IBD suffer from less than optimal efficacies at safe doses, leading to a loss of response...

Continue reading

Cable Internet Users Can Now Get True Gigabit Speeds Throughout a Home with the New Motorola MM1025 2.5 Gbps MoCA Adapter

Minim launches high-speed device on Amazon.com at extremely competitive price — starting at just $99.99 with a two-year warranty and free U.S.-based support MANCHESTER, NH, May 11, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Zoom Telephonics, Inc., doing business as Minim (OTCQB: MINM), the creator of innovative internet access products under the globally-recognized Motorola brand, today launches the Motorola MM1025, the company’s highest-speed multimedia-over-coax-alliance (MoCA) adapter yet. Available for purchase now on MotoManage.com (1-pack, 2-pack) and next week on Amazon.com (1-pack, 2-pack), the Motorola MM1025 delivers up to 2.5 Gbps of high-speed connectivity anywhere in a cable-wired home at the extremely competitive price of $99.99 for a one-pack (MM1025) or $184.99 for a two-pack (MM2025). The price includes an...

Continue reading

Property Management Market to Reach USD 28.21 Billion by 2028; Launch of Rent Relief by Yardi to Augment Growth: states Fortune Business Insights™

List Of Key Companies Profiled in Property Management Market Are AppFolio, Inc. (California, United States), Archibus, Inc. (Massachusetts, United States), CORELOGIC (California, United States), Entrata, Inc. (Lehi, Utah), Yardi Systems, Inc. (California, United States), ManageCasa (California, United States), Planon (Nijmegen, Gelderland), RealPage, Inc. (Texas, United States), SAP SE (Walldorf, Germany), Trimble, Inc. (California, United States), IBM Corporation (New York, United States), MCS Solutions (Antwerp, Belgium) Pune, India, May 11, 2021 (GLOBE NEWSWIRE) — The global property management market size is predicted to reach USD 28.21 billion by 2028, exhibiting a CAGR of 9.3% during the forecast period. The increasing investment in R&D by key players has a positive impact on the market growth during the forecast period....

Continue reading

WPD Pharmaceuticals to Receive $6.7 Million Grant for Development of Annamycin Drug Candidate

VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) — WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical-stage pharmaceutical company, is pleased to announce that it has been conditionally awarded a grant of $6,730,036 (20,394,049.68 PLN) from the Polish National Center for Research and Development (“NCRD”), for the development of Annamycin, the Company’s drug candidate used in the treatment of Acute Myeloid Leukemia (“AML”). Annamycin is a “next generation” anthracycline, that has been shown to be less cardiotoxic compared to other anthracycline, such as doxorubicin, and to avoid multidrug resistance, so the use of Annamycin may not face the same dose limitations imposed on doxorubicin. The project entitled: “A novel approach to the therapy of acute myeloid leukemia (AML)” will...

Continue reading

Amalgamated Financial Corp. Appoints Priscilla Sims Brown Chief Executive Officer

Veteran Financial Services Executive Will Join Amalgamated to Lead its Growth Strategy and Advance its Mission as America’s Socially Responsible BankPriscilla Sims Brown, Incoming President and CEOAmalgamated Financial Corp.Priscilla Sims Brown, Incoming President and CEO with Lynne Fox, Board Chair and Interim President and CEOAmalgamated Financial Corp.NEW YORK, May 11, 2021 (GLOBE NEWSWIRE) — Amalgamated Financial Corp. [Nasdaq: AMAL] (“Amalgamated” or the “Company”), America’s socially responsible bank, today named Priscilla Sims Brown its next President and Chief Executive Officer. Ms. Brown will join Amalgamated on June 1, 2021 from Commonwealth Bank, Australia’s largest bank, where she serves as Group Executive, Marketing and Corporate Affairs, with responsibility for end-to-end marketing,...

Continue reading

L Brands Announces Plan to Separate Bath & Body Works and Victoria’s Secret Into Two Industry-Leading Publicly Traded Companies

– COMPANY PLANS TAX-FREE SPIN-OFF OF VICTORIA’S SECRET TO L BRANDS SHAREHOLDERS – – SEPARATION TO CREATE ENHANCED PROSPECTS FOR LONG-TERM VALUE CREATION – – TRANSACTION EXPECTED TO BE COMPLETED IN AUGUST 2021 – – EXPECTS TO REPORT RECORD FIRST QUARTER EARNINGS – COLUMBUS, Ohio, May 11, 2021 (GLOBE NEWSWIRE) — L Brands, Inc. (NYSE: LB) today announced its Board of Directors has unanimously approved a plan to separate the company into two independent, public companies: Bath & Body Works, one of the world’s leading bath, body and home fragrance retailers, and Victoria’s Secret, including Victoria’s Secret Lingerie, PINK and Victoria’s Secret Beauty, a leading retailer of intimates and beauty products. The company expects to create these companies through a tax-free spin-off of Victoria’s Secret to L Brands’ shareholders. The...

Continue reading

Aleafia Health Reports 2021 First Quarter Results

TORONTO, May 11, 2021 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to report its financial results for the three months ended March 31, 2021 (“Q1 2021”). “This quarter saw us achieve important executional breakthroughs as we realized the exponential increase of our cannabis product portfolio. Likewise, as we benefit from greater scale, we are demonstrating substantial improvements in the profitability of our core adult-use and medical cannabis product sales, contrasting with the broader industry trend of price and margin compression,” said Aleafia Health CEO Geoffrey Benic. “To further leverage product portfolio expansion, we have only just begun the deployment of our highly differentiated medical cannabis ecosystem through the trailblazing exclusive agreement with...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.